印孚瑟斯（Infosys）：2026生命科学2.0：以AI驱动突破研究报告（英文版）（64页）.pdf

1、1Life Sciences Journal 2.0:Driving breakthroughs with AI External Document 2026 Infosys LimitedKnowledge InstituteLIFE SCIENCES JOURNAL 2.0:DRIVING BREAKTHROUGHS WITH AI#BreakthroughsForLife2Life Sciences Journal 2.0:Driving breakthroughs with AI External Document 2026 Infosys LimitedKnowledge Insti

2、tute2Life Sciences Journal 2.0:Driving breakthroughs with AI External Document 2026 Infosys LimitedKnowledge Institute3Life Sciences Journal 2.0:Driving breakthroughs with AI External Document 2026 Infosys LimitedKnowledge InstituteTable of contentsForeword:A compelling moment in thebusiness of brea

3、kthroughs 4Executive summary 6An AI-powered reboot for drug discovery 10The promise of better clinical trial outcomes 20Life sciences CRM:Who really owns the customer?30How to forge a resilient supply chain 38IT makes mergers pay off 47The shift closer to patients 55Contributors 623Life Sciences Jou

4、rnal 2.0:Driving breakthroughs with AI External Document 2026 Infosys LimitedKnowledge Institute4Life Sciences Journal 2.0:Driving breakthroughs with AI External Document 2026 Infosys LimitedKnowledge InstituteLife sciences companies have always been in the business of breakthroughs.What sets this i

5、ndustry apart is the pairing of its relentless pursuit of new discovery with the deeply human mission behind it:to heal,restore,and improve lives.Researchers,scientists,and executives in life sciences organizations carry out this mission with intensity.They know their work touches individuals and fa

6、milies in profoundly personal ways.The tools and discipline required to develop,test,and formulate new therapies are established and well-honed.And the industrys emphasis on innovation has given it remarkable capacity to adopt new methods and technologies to create breakthroughs.This is what makes a